Loading…

Organon & Company (OGN) Stock Analysis | GoodMoat

OGN

OGN

Organon & Company

NYSE · Stock Profile · Market Cap $1.62B

Current Price

$6.23

-2.50%

GoodMoat Value

$36.99

493.8% undervalued

P/E8.66

EPS$0.72

Beta—

P/B2.15

EV/EBITDA7.51

Div Yield5.44%

Did you know?

Trading 494% below its estimated fair value of $36.99.

OGN Price Chart

Market Cap$1.62B

Current Price$6.23

P/E Ratio8.66

Forward P/E—

PEG Ratio-0.03

EPS$0.72

Book Value$2.90

P/B Ratio2.15

FCF vs CAPEX

Forward estimates use 10.2% FCF growth (CAGR)

Cash vs Debt

Net Debt: 8.1B

Revenue

1.6B

FY24

1.6B

FY24

6.4B

FY24

1.5B

FY25

1.6B

FY25

1.6B

FY25

6.2B

FY25

Net Income

195M

FY24

359M

FY24

864M

FY24

87M

FY25

145M

FY25

160M

FY25

187M

FY25

About

Organon & Company

Sector

Healthcare

Industry

Drug Manufacturers - General

Exchange

NYSE

Country

New Jersey, USA

52-Week Range

$6.23

$15.64

50-Day MA: $7.79200-Day MA: $8.63

Did you know?

Trading 494% below its estimated fair value of $36.99.